We are live on ! Find out more
Fairscale Capital

Fairscale Capital Portfolio holdings

AUM $167M Turnover 2.25%
1-Year Est. Return 28.67%
This Fund
S&P 500
This Quarter Est. Return
+18.51%
1 Year Est. Return
+28.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$167M
AUM Growth
+$22.8M
Cap. Flow
+$1.04M
Cap. Flow %
0.62%
Top 10 Hldgs %
52.44%
Holding
444
New
7
Increased
24
Reduced
43
Closed
3
Avg Time Held
1.7 years
Top 10 Avg Time Held
1.7 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$222K
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$126K
3
NVDA icon
NVIDIA
NVDA
+$118K
4
FCX icon
Freeport-McMoran
FCX
+$107K
5
SNPS icon
Synopsys
SNPS
+$101K

Sector Composition

Rank Sector Weight
1 Miscellaneous 52.24%
2 Technology 20.89%
3 Financials 6.18%
4 Communication Services 6%
5 Consumer Discretionary 3.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
UPST icon
426
Upstart Holdings
UPST
$2.31B
$425 ﹤0.01%
12
– –
2024 Q2
8 quarters
PENN icon
427
PENN Entertainment
PENN
$1.94B
$384 ﹤0.01%
18
– –
2024 Q2
8 quarters
OGN icon
428
Organon & Co
OGN
$3.61B
$379 ﹤0.01%
28
– –
2024 Q2
8 quarters
FTRE icon
429
Fortrea Holdings
FTRE
$2.25B
$348 ﹤0.01%
20
– –
2024 Q2
8 quarters
PLUG icon
430
Plug Power
PLUG
$1.93B
$249 ﹤0.01%
92
– –
2024 Q2
8 quarters
DJT icon
431
Trump Media & Technology Group
DJT
$1.78B
$232 ﹤0.01%
30
– –
2024 Q2
8 quarters
KVYO icon
432
Klaviyo
KVYO
$6.01B
$227 ﹤0.01%
15
– –
2024 Q2
8 quarters
GRAL icon
433
GRAIL Inc
GRAL
$5.92B
$205 ﹤0.01%
3
– –
2024 Q2
8 quarters
GLIBK icon
434
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$861M
$194 ﹤0.01%
9
– –
2025 Q3
3 quarters
HSY icon
435
Hershey
HSY
$34.1B
$175 ﹤0.01%
1
– –
2024 Q2
8 quarters
AI icon
436
C3.ai
AI
$2B
$155 ﹤0.01%
17
– –
2024 Q2
8 quarters
ARAY icon
437
Accuray
ARAY
$15.5M
$123 ﹤0.01%
479
– –
2024 Q2
8 quarters
JOUT icon
438
Johnson Outdoors
JOUT
$472M
$46 ﹤0.01%
1
– –
2024 Q2
8 quarters
KD icon
439
Kyndryl
KD
$3.21B
$34 ﹤0.01%
3
– –
2024 Q2
8 quarters
CTXR icon
440
Citius Pharmaceuticals
CTXR
$11.1M
$25 ﹤0.01%
42
– –
2024 Q2
8 quarters
CWH icon
441
Camping World
CWH
$268M
$8 ﹤0.01%
1
– –
2024 Q2
8 quarters
FBRT icon
442
Franklin BSP Realty Trust
FBRT
$518M
– –
-3,111
Closed -$27K –
HOLX icon
443
DELISTED
Hologic
HOLX
– –
-452
Closed -$34.2K –
INOD icon
444
Innodata
INOD
$2.04B
– –
-62
Closed -$2.39K –

Similar funds

Fairscale Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Fairscale Capital held 444 positions worth $167M, up 16% from $145M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Trading was light in Q2 2026: portfolio turnover was 2.3%. Fairscale Capital opened 7 new positions and exited 3, leaving the 444-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, up from 51% a quarter earlier, followed by Technology and Financials.

  • Fairscale Capital's largest Q2 2026 buy was Calamos S&P 500 Structured Alt Protection ETF - June: 7,230 shares worth $200K.
  • Fairscale Capital added most to Invesco QQQ Trust in Q2 2026, an estimated $566K increase.
  • Fairscale Capital's biggest Q2 2026 reduction was Amgen, cutting an estimated $222K.
  • Fairscale Capital fully exited Hologic in Q2 2026, selling an estimated $34.2K.
  • Fairscale Capital's ten largest holdings make up 52% of its $167M portfolio in Q2 2026.
  • Fairscale Capital opened 7 new positions and closed 3 in Q2 2026.
  • Fairscale Capital's portfolio value rose 16% quarter-over-quarter to $167M.

Based on Fairscale Capital's 13F filing for Q2 2026, filed 7 Aug 2026.